LARALAB
LARALAB GmbH • Radiology • 04/16/2025
Device Purpose
The LARALAB software is a stand-alone medical image processing application designed to support cardiovascular procedures through advanced visualization and measurement. It leverages deterministic Deep Learning Algorithms for automatic segmentations and measurements, demonstrating high accuracy and substantial equivalence to existing systems while incorporating cloud-based access.
Summary
The LARALAB software, developed by LARALAB GmbH, is a stand-alone application designed for cardiologists, radiologists, heart surgeons, and other healthcare professionals. It enables users to import, view, and process DICOM compliant medical images, specifically for structures of the heart and vessels. The software features pre-calculated automatic segmentations and measurements based on deterministic Deep Learning Algorithms, which aid in visualizing, assessing, and measuring various anatomical structures for cardiovascular procedures, including preprocedural planning, sizing, and postprocedural image review. The LARALAB software has been determined to be substantially equivalent to an existing medical image management and processing system, the 3mensio Workstation. While both devices share similar intended uses and indications for visualizing and measuring cardiovascular structures, LARALAB incorporates new features such as cloud-based access and automatic preprocessing via deep learning algorithms, which were found not to raise new questions of safety or effectiveness. Comprehensive performance testing, including evaluation of automatic segmentations and measurements against ground-truth values from expert clinicians, demonstrated high accuracy and agreement, meeting all predefined acceptance criteria. An external cybersecurity assessment also confirmed a strong security posture with no critical vulnerabilities.
AI Regulatory Concerns
Powered by
Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.
Keywords
Device Metadata
Relevant Clinical Questions
- Q1. What is the specific performance of the deterministic Deep Learning Algorithms when segmenting and measuring less common or complex cardiovascular pathologies?; Can the LARALAB software integrate with existing hospital Picture Archiving and Communication Systems (PACS) or Electronic Health Records (EHR) for a more streamlined clinical workflow?; What are the specific data encryption and privacy protocols employed for the cloud-based access feature, especially concerning patient identifiable information?; What are the acceptance criteria for 'high accuracy and agreement' in the performance testing against ground-truth values, and how was inter-observer variability accounted for?; Are there plans for continuous updates or retraining of the deep learning algorithms to adapt to new imaging modalities or evolving anatomical nuances?
Risk Classification
ESL AnalysisFDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Qualifies as a cyber device under §524B (post-Dec 2023, networked)
Learn how Parasoft automates IEC 62304 compliance testing →Cybersecurity Evidence
Powered by SBOMator™Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.
Supply Chain BOM Evidence
Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.
Analysis:
• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.
• Evidence of ML-BOM, SaaSBOM, CBOM, VDR/VEX detected in AI-generated device summary.
• SBOM not mentioned in AI-generated device summary. Under §524B (effective Oct 2023), cyber devices must provide a SBOM.
• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.
• Not detected in AI-generated device summary: SBOM, HBOM, OBOM. These may be present in the full FDA submission.
Preparing a similar submission?
ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.
Assess Your Readiness →Or contact ESL directly